← Eichor
Condition: Inflammatory Bowel Disease 5 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Inflammatory Bowel Disease 5

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Confirmatory Clinical Study in Active Ulcerative Colitis
Phase 2 · 16 location(s) · MRM Health NV · NCT07296315
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subject
Phase 4 · 4 location(s) · Bausch Health Americas, Inc. · NCT04314375
Diagnostic Performance of Controlling Nutritional Status as a Nutritional Screening Tool in Patients With Inflammatory B
Phase N/A · 1 location(s) · Hospital General de Mexico · NCT06648551
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagno
NA · 6 location(s) · All India Institute of Medical Sciences · NCT06895252
ACTIVE-IBD Study: Physical Activity and Sleep in Paediatric Inflammatory Bowel Disease
Phase N/A · 1 location(s) · University Hospital Southampton NHS Foundation Trust · NCT05224193
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168
Investigating Serotonin Signalling in IBD Patients
Phase N/A · 1 location(s) · McMaster University · NCT01650311
AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis
NA · 1 location(s) · ENBIOSIS BIOTECHNOLOGIES · NCT07619638
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.